Eprosartan mesilate or mesylate

This classification denotes an angiotensin ii receptor antagonist with the molecular formula C23H24N2O4S.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8N2L1NX8S3, chemically known as (e)-2-butyl-1-(p-carboxybenzyl)-.alpha.-2-thenylimidazole-5-acrylic acid, monomethanesulfonate, but more generally known as eprosartan mesylate, which bears US NIH Compound Identifier 5282474. European Medicines Agency schedules eprosartan mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06586MIG. Most nations, for tariff purposes, schedule eprosartan mesylate under HS 29349990. As of Q4 2014, EPROSARTAN MESYLATE remains US FDA's Preferred Term for this commodity. Eprosartan mesylate bears US NLM identifiers UMLS ID C0772203 and NCI Concept Code C47515. SMILES: CCCCC1NCC(N1CC2CCC(CC2)C(=O)O)/C=C(\CC3CCCS3)/C(=O)O.CS(=O)(=O)O.